Korean Red Ginseng relieves the inflammation and oxidative stress induced by pseudo-typed SARS-CoV-2.

BACKGROUND

Developing antiviral agents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a global goal since the Coronavirus Disease 2019 (COVID-19) pandemic emerged in 2019. Korean Red Ginseng (KRG), recognized for its immunomodulating and antiviral properties, may be effective against SARS-CoV-2. Therefore, we aimed to investigate the efficiency of KRG in a human angiotensin-converting enzyme 2 (hACE2)-expressing mouse model infected with pseudo-typed SARS-CoV-2 (PSV).

METHODS

The lung injury score was assessed using H&E staining, and the immune cell population shift in the lung and spleen was observed through flow cytometry. Serum IgM and IgG concentrations were quantified using enzyme-linked immunoassay (ELISA). Pro-inflammatory cytokine levels were measured by cytometric bead assay (CBA) and polymerase chain reaction (PCR). Additionally, the expression of NLR family pyrin domain containing 3 (NLRP3) and inflammation-related transcription factors was detected by immunoblotting. RNA-sequencing and antibody array assays reconfirmed gene expression in inflammation and oxidation.

RESULTS

KRG extract was most effective in treating lung injuries and serum IgM and IgG levels. Also, immune cells, including neutrophils, were regulated in the lungs, and tumor necrosis factor-alpha (TNF-a) levels were reduced. NLRP3 and phosphorylated nuclear factor-κB (NF-kB) and activator protein 1 (AP-1) were downregulated. Heme oxygenase-1 (HO-1) expression was increased, indicating that KRG extract has antioxidant properties. RNA-sequencing and antibody array assays revealed that KRG extract regulates the expression of genes associated with inflammation and oxidative damage.

CONCLUSIONS

This study demonstrates that KRG extract may suppress PSV-induced inflammation and oxidative stress, making it a viable antiviral functional food.